And there you have it. Catherine Owen-Jones is out to turn ACAD into a Global Neuro Drug Powerhouse.
It’s hard to imagine she could not be casting her greedy eyes over 2591.
2591 is all she needs to be a Global Powerhouse. How does she put together deal that gives her control.
With a $Billion in sales and growing she’s got access to debt funding. She’s got access to Capital Funding. She’s got shares she can swap out. She got $700M in cash.
Watch closely we’ve got a very exciting few months ahead.
And there you have it. Catherine Owen-Jones is out to turn ACAD...
Add to My Watchlist
What is My Watchlist?
